Elixirr International Plc (GB:ELIX)
LSE:ELIX
Want to see GB:ELIX full AI Analyst Report?
Top Page
Elixirr International Plc
(LSE:ELIX)
Select Model
Select Model
Rating:76Outperform
Price Target:
766.00 p
▼(-8.81% Downside)
Action:Reiterated
Date:04/22/26
The score is driven primarily by strong financial fundamentals (scaled revenue, healthy margins, solid returns), tempered by increased 2025 leverage and weaker operating cash support. Technicals are supportive with positive momentum but show near-term overbought risk and lingering overhead versus the 200-day average. Valuation is reasonable but not notably cheap, and the dividend yield is modest.
Positive Factors
Multi-year revenue scaling
Sustained revenue expansion over several years indicates persistent client demand and successful commercial scaling. Larger revenue base supports diversified client exposures, repeat engagements, and the ability to invest in delivery capability, improving resilience of fee income over the medium term.
Negative Factors
Sharp rise in debt
A material increase in absolute debt and leverage versus the prior low-leverage profile reduces financial flexibility and raises interest and covenant risk. Higher debt amplifies sensitivity to cash-flow volatility and limits capital allocation optionality during slower demand periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue scaling
Sustained revenue expansion over several years indicates persistent client demand and successful commercial scaling. Larger revenue base supports diversified client exposures, repeat engagements, and the ability to invest in delivery capability, improving resilience of fee income over the medium term.
Read all positive factors
Elixirr International Plc (ELIX) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£350.32M
Dividend Yield2.13%
Average Volume (3M)101.98K
Price to Earnings (P/E)17.0
Beta (1Y)1.03
Revenue Growth34.36%
EPS Growth18.76%
CountryUK
Employees565
SectorIndustrials
Sector Strength72
IndustryConsulting Services
Share Statistics
EPS (TTM)0.41
Shares Outstanding50,853,348
10 Day Avg. Volume75,512
30 Day Avg. Volume101,977
Financial Highlights & Ratios
PEG Ratio1.18
Price to Book (P/B)2.76
Price to Sales (P/S)2.63
P/FCF Ratio12.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£1,060.00Price Target Upside26.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.65
Revenue Forecast (FY)£185.75M
Elixirr International Plc Business Overview & Revenue Model
Company Description
Elixirr International plc, along with its various subsidiaries, delivers expert management consulting services across the United Kingdom, the United States, and other international territories. The company's core offerings encompass creative strat...
How the Company Makes Money
Elixirr primarily makes money by selling consulting and professional services to client organisations. Revenue is generated through fees for advisory work (e.g., strategy, transformation design, operating model and performance improvement) and del...
Elixirr International Plc Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
76
Positive
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 149.60M | 111.34M | 85.89M | 71.75M | 50.61M |
| Gross Profit | 44.80M | 35.81M | 29.26M | 23.16M | 17.70M |
| EBITDA | 39.55M | 27.96M | 25.78M | 20.02M | 14.46M |
| Net Income | 19.70M | 16.38M | 17.24M | 12.87M | 10.14M |
Balance Sheet | |||||
| Total Assets | 251.08M | 175.89M | 154.40M | 128.66M | 107.17M |
| Cash, Cash Equivalents and Short-Term Investments | 5.05M | 7.53M | 18.13M | 20.43M | 31.80M |
| Total Debt | 33.52M | 4.90M | 5.36M | 5.14M | 5.25M |
| Total Liabilities | 108.56M | 43.78M | 34.84M | 32.74M | 21.13M |
| Stockholders Equity | 142.53M | 132.11M | 119.56M | 95.92M | 86.04M |
Cash Flow | |||||
| Free Cash Flow | 31.48M | 28.76M | 16.67M | 15.40M | 14.23M |
| Operating Cash Flow | 31.55M | 28.84M | 16.79M | 15.73M | 14.33M |
| Investing Cash Flow | -36.56M | -21.11M | -14.82M | -18.53M | -3.24M |
| Financing Cash Flow | 2.92M | -18.58M | -4.06M | -8.85M | 3.11M |
Elixirr International Plc Technical Analysis
Negative
840.00
Price Trends
717.92
Negative
699.68
Negative
758.69
Negative
Market Momentum
-6.23
Positive
46.01
Neutral
21.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Negative. The current price of 840 is above the 20-day moving average (MA) of 710.00, above the 50-day MA of 717.92, and above the 200-day MA of 758.69, indicating a bearish trend. The MACD of -6.23 indicates Positive momentum. The RSI at 46.01 is Neutral, neither overbought nor oversold. The STOCH value of 21.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ELIX.
Elixirr International Plc Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.25B | 15.85 | 16.69% | 1.27% | 1.69% | 276.44% | |
77 Outperform | £255.40M | 20.98 | 6.46% | 3.68% | 2.11% | 818.58% | |
76 Outperform | £350.32M | 16.98 | 15.00% | 2.13% | 34.36% | 18.76% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £597.32M | 18.26 | 9.94% | 1.19% | 12.82% | 16.40% | |
60 Neutral | £72.07M | 15.81 | 6.42% | 8.80% | 6.04% | -24.55% | |
45 Neutral | £366.52M | -2.24 | -142.88% | ― | -7.30% | -311.68% |
* Industrials Sector Average
GB:ELIX
Elixirr International Plc
696.00
41.41
6.33%
GB:CPI
Capita plc
306.00
29.00
10.47%
GB:GTLY
Gateley (Holdings)
52.50
-65.27
-55.42%
GB:DATA
GlobalData
80.70
-62.39
-43.60%
GB:SRP
Serco Group plc
228.40
34.00
17.49%
GB:YOU
Yougov plc
218.00
-123.25
-36.12%
Elixirr International Plc Corporate Events
Business Operations and StrategyDividendsShareholder Meetings
Elixirr Sets AGM Date and Confirms Final Dividend Timetable
Positive
Jun 2, 2026
Elixirr International has published its notice of Annual General Meeting, to be held on 30 June 2026 at the Royal Berkshire Hotel in Ascot, with the AGM materials and 2025 Annual Report made available both via the National Storage Mechanism and on...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Elixirr issues new shares to settle TRC acquisition earn-out
Positive
May 20, 2026
Elixirr International has issued 822,194 new ordinary shares to satisfy the equity component of contingent consideration tied to the 2025 performance of its acquired U.S. advisory firm TRC Advisory, valuing the issuance at £5.9 million. The n...
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
Elixirr Publishes 2025 Annual Report as It Expands Global Challenger Consultancy Model
Positive
Apr 29, 2026
Elixirr International has published its Annual Report for the year ended 31 December 2025 on its investor website and submitted the document to the UK Financial Conduct Authority’s National Storage Mechanism. Shareholders who have opted for ...
Business Operations and StrategyPrivate Placements and Financing
Elixirr Completes Oversubscribed £12m Secondary Share Placing
Positive
Apr 28, 2026
Elixirr International plc, the London-listed challenger consultancy, has built a diversified global presence by working collaboratively with clients and augmenting its services through the acquisition of nine specialist boutique firms. The company...
Business Operations and StrategyPrivate Placements and Financing
Elixirr launches £12m secondary share placing to meet institutional demand
Positive
Apr 28, 2026
Elixirr International plc has announced a £12 million secondary placing of existing ordinary shares at 750 pence per share, targeting institutional investors via an accelerated bookbuild run by Cavendish Capital Markets. The sale is being car...
Business Operations and StrategyDelistings and Listing ChangesDividendsFinancial DisclosuresM&A Transactions
Elixirr posts record 2025 results as AI-led consulting drives 34% revenue surge
Positive
Apr 20, 2026
Elixirr International reported record results for 2025, with revenue rising 34% to £149.6m and adjusted EBITDA up 42% to £44.3m, driven by strong demand for AI-enabled advisory work and disciplined execution. The group lifted its total d...
Business Operations and StrategyFinancial Disclosures
Elixirr Schedules Live Investor Presentation on FY25 Results
Positive
Mar 27, 2026
Elixirr International will host a live investor presentation on 21 April 2026 to discuss its full‑year 2025 results, which are scheduled for release on 20 April 2026. The session, led by senior executives including the CEO, Deputy CEO, CFO a...
Business Operations and StrategyExecutive/Board Changes
Elixirr grants new share options to senior leadership
Positive
Mar 23, 2026
Elixirr International has granted 444,912 share options over ordinary shares to its executive directors and other senior managers, representing about 0.89% of its issued share capital. The options, priced at 645 pence with a five-year vesting peri...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.